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Abstract:

Two experiments were carried out in this study: 1). Genotyping DNA samples of
Toxoplasma gondii collected from the National Institute of Health (NIH) and 2). Performing
Multiple Agglutination Tests (MAT) of feral cat samples collected from Knoxville, TN. Chicken
DNA samples were genotyped using a series of PCR techniques followed by endonuclease
restriction and an electrophoresis gel. Different molecular markers were amplified using specific
primers to bind to certain sites of target DNA. This process will help allow the identification of
strain types of the DNA samples in the given geographical area. After reviewing gel results, the
data highlighted inconsistencies due to low DNA sample concentrations. Additionally, MAT
tests were performed in order to better understand the initial scope of infection for T. gondii.
Approximately 37% percent of the sample serums had tested positive for T. gondii.
Introduction:
Toxoplasma gondii is an obligate and intracellular parasite that causes the disease
toxoplasmosis. It is a coccidian parasite in which an estimated ~30 percent of the world’s
population has been exposed to and chronically infected (Pernas, 2014). In 1908, Charles Nicolle
and Louis Manceaux found the parasite as they were studying a protozoan organism in the
tissues of a rodent called the gundi (Weiss, 2011). Today, T. gondii is one of the most well
studied parasites because of its significance in the medical and veterinary field. For example,
there are a multitude of research articles highlighting the molecular epidemiology, pathology,
physiology, and cell biology of the parasite.
The sexual reproduction of T. gondii takes place in the intestines of felines, which is the
definitive host. Asexual reproduction takes place in the intermediate host, including mammals
and birds. A life cycle of T. gondii begins when a cat shed oocysts through their feces.
Intermediate hosts become infected after ingesting soil, water, or plant material contaminated
with oocysts (CDC, 2015). Parasites develop into chronic phase, which is in tissue cyst, localized
in neural and muscle tissue cells (CDC, 2015). Cats can be infected after consuming intermediate
hosts with tissue cysts such as mice. Humans can become infected mainly by the consumption of
uncooked meat with tissue cysts and consumption of water or food contaminated with cat feces
(oocysts). Developing fetus can also get infected from pregnant woman who has primary
infection.
There are three infectious stages of T. gondii. The first stage is the tachyzoites, where
cells are rapidly multiplying. Tachyzoites multiply asexually within the host cell by repeated
endodyogeny (a specialized form of reproduction in which two progeny form within the parent
parasite (Dubey, 2010). They are responsible for establishing the acute phase of infection during
dissemination via the bloodstream to the various tissues (Pernas, 2014). The rate of invasion and
growth can vary depending on the specific strain of T. gondii and host cells. After the tachyzoites
makes its way into a host cell, there is a variable period of lag phase before the parasite divides
and this phase is partly parasite dependent. The second stage is the bradyzoites, which is the
encysted stage of the parasite in tissues and establishes the chronic phase of infection. These
tissue cysts differ structurally from tachyzoites in that they have a nucleus situated towards the
posterior end rather than a more centrally located nucleus. Tissue cysts serve as an integral part
of the life cycle and can be formed in 3 days after inoculation. The last stage is the oocysts. Cats
shed oocysts after ingesting any of the three infectious stages of T. gondii.

Geographically, T. gondii infection in humans and animals is widespread around the
world and are more prevalent in some parts than others. Environmental conditionals may
determine the degree of natural spread of T. gondii infection. Infection is more prevalent in warm
and humid climates and low-lying areas than in cold, dry, and mountainous climates (Dubey,
2010). Additionally, cultural habitats and hygiene of people may play a role. For example,
France has been suggested to have a high seroprevalence of T. gondii (Pappas, 2009). This can
be due to the cooking and eating habits of the French, where eating raw or undercooked meat
indicates a high standard of living (Dubey, 2010). On the contrary, countries such in Asia and
Africa cook their meats well due to the presence of many other prominent parasites that people
are afraid they may consume.
In this study, specific PCR-RFLP markers were chosen for genotyping because they have
been widely used in identifying T. gondii isolates from a variety of hosts in different
geographical regions. All ten markers together can help distinguish the three strains with high
resolution. MAT Tests, on the other hand, helps to gain a better insight on how infected a DNA
sample is by observing the presence of pellet (antigen).
Methods:
Genotyping
A total of 18 NIH DNA samples (TX 54 and 60) in 1:5 dilutions were tested in the
genotyping process. Additionally, 8 positive controls and 3 negative controls were included. The
methodology used in this study was adopted from “Moving towards Integrated Genotyping and
Diagnosis of Toxoplasmosis.”
To begin, a Multiplex Polymerase Chain Reaction (PCR) was performed to amplify and
obtain more genomic DNA using a mix of primers (SAG1, 3’-SAG2, alternative SAG 2, BTUB,
GRA6, c22-8, c29-2, L358, PK1, Apico). The following reagents were assembled for the
multiplex PCR mix: distilled water (16.5 µL
L), 10x Mg- PCR buffer (2.5 µL),
L), dNTPs (2.5mM; 2.0
µL),
L), MgCl2 (25mM; 2.0 µL),
L), mixed external forward primer (25mM; 0.15 µL),
L), mixed external
reverse primer (25mM; 0.15 µL),
L), and FastStart Taq (5U/ µL);
L); 0.20 µL).
L). The amount of each
reagent is the standard value for one sample. Hence, the values were multiplied by 29 (total
samples including +/- controls), bringing the total volume of the M-PCR mix to 681.5 µL.
L. Next,
23.5 µL
L of the PCR mix and 1.5 µL
L of the DNA samp
samples were added into each microtube well on
a PCR plate for all 29 samples based on Template 1. The samples were then heated in a
thermocycler at 95°C for 4 minutes, then 30 cycles of 94°C for 30 seconds, 55°C for 1 min, 72°C
for 2min, and lastly soaked at 15°C. The finished product from this M-PCR will be used in the
following step of N-PCR.
After multiplex PCR, the DNA samples underwent a Nested PCR to further amplify
DNA using specific primers in order to bind certain sites of the DNA. These primers will be the
each individual primers for the markers used in the multiplex instead of all primers combined.
The reagents used in this N-PCR mix were similar to the M-PCR, including distilled water (18.5
µL),
L), 10x MgMg PCR buffer (2.5 µL),
L), dNTPs (2.5mM; 2.0 µL),
L), nested forward primer (25mM; 0.15
µL),
L), nested reverse primer (25mM; 0.15 µL),
L), and Paq5000 polymerase (5U/ µL);
L); 0.20 µL).
L). For
marker SAG1, the forward and reverse primers are SAG1-S2 and SAG1-Rext, respectively. For
marker 5’-SAG2, the forward and reverse primers are 5-SAG2F and 5-SAG2R, respectively.

Only two markers were conducted due to error in DNA samples – see results. Again, the value of
each reagent was multiplied by 29 (total samples including +/- controls), bringing the total
volume of the N-PCR mix to 681.5 µL.
L. The same amount of 23.5 µL
L PCR mix and 1.5 µL
L of
extracted DNA sample were added into each microtube well on a PCR plate for all 29 samples.
The samples were heated in a thermocycler at 95°C for 4 minutes, then 35 cycles of 94°C for 30
seconds, 60°C for 1 min, 72°C for 2min, and lastly soaked at 15°C. The finished product from
this M-PCR will be used in the following step of restriction.
Following the two sets of PCR, the DNA samples underwent digestion via Restriction
Fragment Length Polymorphism (RFLP). Restriction enzymes called endonucleases were used in
order to cut specific parts of the DNA for analysis. The digestion mix included distilled water
(14.6 µL
L), 10x NEB buffer (2.0 µL
L), and restriction enzyme(s) (0.1 µL
L). The restriction enzymes
used for marker SAG1 were Sau96I and HaeII (double digest). The restriction enzyme used for
5’-SAG2 was MboI. 17 µL
L of digestion mix and 3 µL
L of N-PCR products were added to a
microtube PCR plate. All samples were then incubated for 1 hour in a 37°C hot water bath.
Lastly, a 2.5% agarose gel was prepared for gel electrophoresis with the RFLP samples to
confirm the gel results with the known positive control gel data. Gel electrophoresis separated
the DNA fragments based on their size and works on the basis of electrical charge. The results
are shown in Figures 1 and 2.
Template 1. Multiplex & Nested PCR Template (TX54 & TX60)

A
B
C
D
E
F
G
H

1
Neg Control
TX54 CK618OP
TX54 CK619OP
TX54 CK620OP
TX54 CK621 OP
TX54 CK622 OP
TX54 CK623 OP
TX54 CK625 OP

2
TX54 CK627 OP
TX54 CK628 OP
TX54 CK629 OP
TX54 CK630 OP
Neg Control
TX54 CK631 OP
TX60 CK618
TX60 CK619

3
GT1
PTG
CTG
TgCgCa1
MAS
TgBr5
TgbBr64
TgToucan

4
TX60 CK620
TX60 CK621
Neg Control
TX60 CK622
TX60 CK623
Empty
Empty
Empty

Legend
Yellow = Positive Control
Green = Negative Control

Modified Agglutination Test (MAT Test)
For the first round of test to identify seropositive samples, a total of 97 DNA serums were
diluted 1:25 with 1x PBS in 1.5mL tubes (72 µL
L of PBS and 3 µL
L of sample serum). 50 µL
L of
diluted samples were transferred to the first and fith rows of a U-bottom 96 microtiter plate
(which included 20 sample serums, 1 negative control, and 1 positive control. The rest of the
wells had 25 µL
L of PBS added using a multichannel pipette. Next, a serial dilution was made to
1:200 for each sample (Template 2), but 1:3200 for negative and positive controls (Template 3).
The last 25 µL
L of diluted serum samples were discarded. An antigen mixture was prepared,
including alkaline buffer (2500 µL
L), 2-mercaptothanol (35 µL), Evans blue dye (2mg/mL in H2O;
50 µL
L), T. gondii MAT antigen (150 µL
L). 25 µL
L of the antigen mixture was immediately
transferred into each well on the plate. Lastly, the plate was covered with sealing tape and

incubated at 37°C for 24 hours. After the results were collected, the plates were placed in the
fridge at 4°C for another 24 hours. Results were checked again to verify the accuracy.
After testing was completed for all 97 samples, samples that tested positive were tested
again in a 1:3200 serial dilution (Template 3). The same procedures were followed and results
were collected at 24 hours after 37°C incubation and collected again after another 24 hours at
4°C.
Template 2. 1:200 serial dilution of serum samples in 96-well plate (20 total samples).

Template 3. 1:3200 serial dilution of serum samples in 96-well plate (10 total samples).

Results:
Results collected from genotyping are shown in Figures 1a and 1b. The gel images of
positive controls all looked normal and correct. However, all tested DNA samples indicated
separated bands, suggesting some degree of error.
rom MAT tests are organized in T
Tables 1 through 9,, depicting which
Results collected from
tested DNA samples were infected
infected. Positive samples have no pellets present on the bottom of
each well since antibodies (present in infected samples) are bound to the antigen. On the other
hand, pellets were observed for negative samples as there are no antibodies in a negative sample,
allowing the antigen to form a pellet on the bottom. MAT Testing of all 97 samples suggested
that 37 samples tested positive. After a second MAT Test for all 37 positive samples, 36 were
positive. Ultimately,
y, results depict that 36 samples out of 97 were infected with T. gondii.
gondii

Figure 1a. Gel results for SAG1 marker, HaeIII + Sau96 double digest.

Figure 1b. Gel results for SAG1 marker (known positive controls).

SAG2 marker
marker, MboI digestion.
Figure 2a. Gel results for 5’-SAG2

Figure 2b. Gel results for 5’-SAG2
SAG2 marker (known positive controls).

Table 1. MAT Test results of first 20 samples.

Table 2. MAT Test results for second set of 20 samples.

Table 3. MAT Test results for third set of 20 samples.

Table 4. MAT Test results for fourth set of 20 samples.

Table 5. MAT Test results for fifth/last set of 20 samples.

Table 6. MAT Test results for first set of positive samples
samples.

Table 7. MAT Test results for second set of positive samples.

Table 8. MAT Test results for third set of positive samples.

Table 9. MAT Test results for fourth set of positive samples.

Table 10. Box #6 MAT Test Summary (Sample Collected: 7/17/2010)
Sample ID

Titer

521-4
521-5
521-6
521-7
521-8
521-9
521-10

Negative
Negative
Negative
• 3200
Negative
Negative
• 3200

521-4
521-11
521-12
520-1
520-2
520-3
520-4
520-5
520-6
521-2
521-3
521-4
516-1
516-2
516-3 #1
516-3 #2
517-1
518-2
518-1
519-1
519-2
519-3
513-7
514-1
514-2
514-3 #1
514-3 #2
514-4
514-6
514-7
515-1
515-2
507-4
512-1
512-2
512-3
511-4
513-1
513-2
513-3
513-4
513-5
513-6
504-4
504-3
504-2

Negative
Negative
• 3200
• 3200
Negative
Negative
Negative
Negative
Negative
• 3200
Negative
Negative
Negative
• 3200
Negative
Negative
Negative
Negative
Negative
Negative
Negative
• 3200
• 3200
Negative
Negative
Negative
Negative
Negative
Negative
• 3200
• 3200
• 3200
• 3200
Negative
Negative
Negative
Negative
• 3200
• 3200
Negative
200
Negative
• 3200
• 3200
Negative
• 3200
200

504-1
500-6
503-7
503-6
503-5
503-4
503-3
503-1
507-1
507-2
507-3
507-5
508-1
508-3
508-4
506-3
506-2
505-1
505-2
505-3
505-4
505-5
505-6
505-7
503-8
503-10
503-11
500-5
500-4
500-3
500-2
500-1
501-2
501-1
502-2#3
502-1
503-9
509-2
504-5
509-1
510-1
511-3
511-1
506-1
Discussion:

• 3200
• 3200
Negative
200
Negative
200
200
Negative
Negative
• 3200
• 3200
• 3200
• 3200
• 3200
Negative
Negative
• 3200
• 3200
Negative
Negative
Negative
Negative
Negative
• 3200
• 3200
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
• 3200
Negative
200
Negative
Negative
Negative
• 3200
Negative
Negative
Negative

The unsuccessful genotyping results from the gel were most likely due to low DNA
sample concentrations. The reason is because all the bands of positive controls on the gel were
correct after comparing it to known positive controls. This means that this would not be due to
technique error. After further analysis, it was concluded that the separated bands indicate
minimal contamination due to low DNA concentrations. Minimal contamination would have
been negligible of a sample of higher concentration. Therefore, future studies should utilize
original DNA concentration instead of 1:5 dilutions.
The second MAT test helps to confirm all positive samples from initial MAT Test. Only
1 out of all 37 positive samples turned out negative, so approximately 97% (36/37) initial
positive samples tested positive again during the second confirmation test. The one sample that
turned negative can be an error in reading the initial MAT test results, as there can be fog
forming underneath the plate when taken out of the 4°C fridge. Overall, this represents that 37%
(36/97) of feral cat samples in Knoxville were infected with T. gondii. This data is reasonable
because it is estimated that T. gondii infects about one-third of the world’s human population
(Perna, 2014).
For future studies, DNA samples from different years can be tested since infection rates
differ as time changes. Furthermore, testing samples from varying environmental
conditions/features can also be an important study. For example, infection rates of organisms
may change when comparing a rural area to an urban landscape. To better understand and verify
if an organism has an infection, the host's organ tissue can be harvested and inoculated in mice
(in the hopes the some tachyzoites are inoculated). This would be a good verification since
virulence was first tested in mice; and thus, symptoms are more understood in mice. Lastly, the
sample size in this study was low (97 samples). Hence, future studies can also incorporate testing
of more samples (approximately 2,000 samples) through a longer span of time to help improve
consistency and accuracy of results.

References:
"Biology of Toxoplasma Gondii." Centers for Disease Control and Prevention (CDC). Global
Health – Division of Parasitic Diseases and Malaria, 17 Mar. 2015. Web. 22 Apr. 2015.
<http://www.cdc.gov/parasites/toxoplasmosis/biology.html>.
Dubey, J. P. Toxoplasmosis of Animals and Humans. 2nd Ed. Boca Raton, FL: CRC, 2010. Print.
Pappas, G; Roussos, N; Falagas, ME (October 2009). "Toxoplasmosis
snapshots: global status of Toxoplasma gondii seroprevalence and implications for
pregnancy and congenital toxoplasmosis.” International Journal for Parasitology 39
(12): 1385–94.
Pernas, L.; Ramirez, R.; Holmes T.; Montoya, J.; Boothroyd; J. (March 2014). “Immune Profiling
of Pregnant Toxoplasma- Infected US and Colombia Patients Reveals Surprising Impacts
of Infection on Peripheral Blood Cytokines.” The Journal of Infectious Diseases
2014; 210:923–31•.
Weiss, LM; Kim, K (2011). Toxoplasma Gondii: The Model Apicomplexan. Perspectives and

Methods. London: Academic Press/Elsevier. pg 49–80.

